PSYCHEMEDICS CORP Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Psychemedics Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q3 2024.
  • Psychemedics Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $228K, a 43.1% decline year-over-year.
  • Psychemedics Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $987K, a 9.79% increase year-over-year.
  • Psychemedics Corp annual Share-based Payment Arrangement, Expense for 2023 was $908K, a 4.13% increase from 2022.
  • Psychemedics Corp annual Share-based Payment Arrangement, Expense for 2022 was $872K, a 17.4% increase from 2021.
  • Psychemedics Corp annual Share-based Payment Arrangement, Expense for 2021 was $743K, a 32% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $987K $228K -$173K -43.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.16M $275K +$132K +92.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.03M $297K +$120K +67.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $908K $187K +$9K +5.06% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $899K $401K +$124K +44.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $775K $143K -$95K -39.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $870K $177K -$2K -1.12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $872K $178K -$1K -0.56% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $873K $277K +$99K +55.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $774K $238K +$69K +40.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $705K $179K -$38K -17.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $743K $179K +$65K +57% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $678K $178K +$52K +41.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $626K $169K +$9K +5.63% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $617K $217K +$54K +33.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $563K $114K -$136K -54.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-27
Q3 2020 $699K $126K -$64K -33.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $763K $160K -$1K -0.62% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $764K $163K +$5K +3.17% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $759K $250K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-30
Q3 2019 $190K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $161K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $158K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.